U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151391) titled 'The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)' on Aug. 20.

Brief Summary: The purpose of this clinical trial is to learn if the drug guarana improves symptoms of fatigue in patients with neuroendocrine tumors and gynecologic cancers

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Neuroendocrine Tumors Gynecologic Cancer

Intervention: DRUG: Guarana

500 mg oral medication daily

DRUG: Placebo

Oral medication daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: University of Utah

Published by HT Digital Content Services with permissio...